NCT01440023
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- The Psychology Clinic, University of Wisconsin-Milwaukee Milwaukee, Wisconsin, United States
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
9,000 public trials
1,758 recruiting studies
Neurodegenerative Diseases trial results
NCT00337636
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
NCT02169895
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Algorithme Pharma Inc Mount Royal, Quebec, Canada
NCT02101190
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Biotrial, 7-9 rue Jean-Louis Bertrand Rennes, France
- City clinical Hospital N°64 Moscow, Russia
- City clinical Hospital N°3 Moscow, Russia
NCT00423228
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- Central Coast Neuroscience Research East Gosford, New South Wales, Australia
- Hornsby-Kuring-gai Health Service Hornsby, New South Wales, Australia
- Southern Neurology Kogarah, New South Wales, Australia
- The Prince Charles Hospital Chermside, Queensland, Australia
NCT02092168
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- BIOTRIAL Rueil, Malmaison, France
Completed
Mexiletine and Non Dystrophic Myotonias
NCT02336477
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +9 more
- Locations
-
- Groupe Hospitalier Pitié Salpetriere Paris, France
Completed
A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
NCT01568034
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Department of Neurology-Hospital de Santa Maria-Faculty of Medicine, University of Lisbon Lisbon, Portugal
- Spitalul Clinic Colentina - Clinica de Neurologie Bucharest, Romania
- Department of Neurology- Hospital of the department of medical care of Ministry Internal Affairs of Ukraine Kyiv, Ukraine
NCT00866502
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Lund University Hospital Lund, Sweden
- Karolinska University Hospital, Huddinge Stockholm, Sweden
Completed
Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites
NCT01515891
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Covance Basel Research Unit AG (formerly Swiss Pharma Contract Ltd) Allschwil, Base, Switzerland